Ronald T. Piervincenzi

Ron is the Chief Executive Officer of the U.S. Pharmacopeial Convention (USP). Previously, he was a partner in McKinsey and Company’s pharmaceutical practice where he led McKinsey’s global drug safety and regulatory service line. At Biogen Idec, he launched the Value-Based Medicine division, which focuses on personalized medicine in motor disorders.